Leverage our fully integrated research platforms and therapeutic area expertise to power your drug discovery and development programs. We offer both flexible CRO essentials and premium services combined with scientific consulting to optimize success at every stage. Our integrated collaboration models deliver seamless project support for faster, smarter outcomes.
Our Integrated Solutions
- Sourcing Novel Ideas
- Target ID / Validation
- Hit Identification
- Lead Optimization
- Preclinical Development
- Clinical Phase I/II/III
- Approval to Market
We support your program needs by seamlessly and flexibly navigating from target ID to lead optimization. While we excel in standalone CRO services, our capabilities extend into integrated deals and strategic partnerships creating additional growth and value through proprietary technology and therapeutic area expertise.
Integrated projects within our shared R&D platform benefit from additional synergy between our discovery and development teams. They collaborate to identify the top preclinical drug candidate, advancing it seamlessly to IND. With that, we ensure rapid progress, success, asset value, and cost reduction. Quality remains central throughout.
A continuous focus on quality, coupled with early management of liabilities, instills confidence in the viability of development. Selected candidates can seamlessly transition to our IND-enabling phase, an all-encompassing clinical enabling program, which expedites the progression of early drug candidates into clinical trials by curtailing the duration between nomination and regulatory submission.
- INDiGO-Select & INDiGO®
- API Process Development & Manufacturing
- API & Drug Product Commercial Manufacturing
- Analytical Development, Quality Control & Stability
- Material Science
- Early Formulation
- Drug Product Development & Manufacturing
- Safety Assessment
- Abuse Liability Assessment
- Bioanalysis
- Pharmacometrics
- Regulatory Support
- Clinical Development & Translational Medicine
